Associations of renal function at 1-year after kidney transplantation with subsequent return to dialysis, mortality, and healthcare costs

Transplantation

Volumn 91, Issue 12, 2011, Pages 1347-1356

  Schnitzler, Mark A ^a   Johnston, Karissa ^b   Axelrod, David ^c   Gheorghian, Adrian ^a   Lentine, Krista L ^a,d  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ICON PLC   (United Kingdom)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Glomerular filtration rate; Graft failure; Healthcare costs; Kidney transplantation; Medicare; Mortality

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIALYSIS; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; HEALTH CARE COST; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; MEDICARE; MORTALITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE COSTS; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MEDICARE; MIDDLE AGED; REGRESSION ANALYSIS; RENAL DIALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 79958717951     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31821ab993     Document Type: Article

References (33)

1. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605.
2. Machnicki G, Seriai L, Schnitzler M. Economics of transplantation: A review of the literature. Transplant Rev 2006: 20: 61.
3. Gill JS, Tonelli M, Mix CH, et al. The change in allograft function among long-term kidney transplant recipients. J Am Soc Nephrol 2003; 14: 1636.
4. Hariharan S, McBride MA, Cherikh WS, et al. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002; 62: 311.
5. Schnitzler MA, Whiting JF, Brennan DC, et al. The expanded criteria donor dilemma in cadaveric renal transplantation. Transplantation 2003; 75: 1940.
6. Humar A, Kerr S, Gillingham KJ, et al. Features of acute rejection that increase risk for chronic rejection. Transplantation 1999; 68: 1200.
7. Ishikawa A, Flechner SM, Goldfarb DA, et al. Significance of serum creatinine pattern and area under the creatinine versus time curve during the first acute renal transplant rejection. Transplant Proc 2000; 32: 781.
8. Coates PT. The CARI guidelines. Calcineurin inhibitors in renal transplantation: Nephrotoxicity and calcineurin inhibitors. Nephrology (Carlton) 2007; 12(suppl 1): S85.
9. Nicol D, MacDonald AS, Lawen J, et al. Early prediction of renal allograft loss beyond one year. Transpl Int 1993; 6: 153.
10. Kaplan B, Schold J, Meier-Kriesche HU. Poor predictive value of serum creatinine for renal allograft loss. Am J Transplant 2003; 3: 1560.
11. He X, Moore J, Shabir S, et al. Comparison of the predictive performance of eGFR formulae for mortality and graft failure in renal transplant recipients. Transplantation 2009; 87: 384.
12. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089.
13. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.NEngl J Med 2004; 351: 1296.
14. Matsushita K, van der Velde M, Astor BC, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 2010; 375: 2073.
15. Smith DH, Gullion CM, Nichols G, et al. Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 2004; 15: 1300.
16. Lentine KL, Xiao H, Machnicki G, et al. Renal function and healthcare costs in patients with polycystic kidney disease. Clin J Am Soc Nephrol 2010; 5: 1471.
17. Marcen R, Pascual J, Tenorio M, et al. Chronic kidney disease in renal transplant recipients. Transplant Proc 2005; 37: 3718.
18. London R, Solis A, Goldberg GA, et al. Health care resource utilization and the impact of anemia management in patients with chronic kidney disease. Am J Kidney Dis 2002; 40: 539.
19. Sinha R, Saad A, Marks SD. Prevalence and complications of chronic kidney disease in paediatric renal transplantation: A K/DOQI perspective. Nephrol Dial Transplant 2010; 25: 1313.
20. Costa de Oliveira CM, Mota MU, Mota RS, et al. Prevalence and staging of chronic kidney disease in renal transplant recipients. Clin Transplant 2009; 23: 628.
21. Jimenez Alvaro S, Marcen R, Teruel JL, et al. Management of chronic kidney disease after renal transplantation: Is it different from nontransplant patients? Transplant Proc 2009; 41: 2409.
22. Lefebvre P, Duh MS, Buteau S, et al. Medical costs of untreated anemia in elderly patients with predialysis chronic kidney disease. J Am Soc Nephrol 2006; 17: 3497.
23. Brennan DC, Schnitzler MA. Long-term results of rabbit antithymocyte globulin and basiliximab induction. N Engl J Med 2008; 359: 1736.
24. Vincenti F, Larsen C, Durrbach A, et al. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 2005; 353: 770.
25. Srinivas TR, Flechner SM, Poggio ED, et al. Glomerular filtration rate slopes have significantly improved among renal transplants in the United States. Transplantation 2010; 90: 1499.
26. Researcher's Guide to the United States Renal Data System Database, 2008. Available at: http://www.usrds.org/research.htm. Accessed September 20, 2010.
27. Levey AS, Greene T, Kusek JW, et al. A simplified equation to prediction glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: 155A.
28. Poggio ED, Wang X, Weinstein DM, et al. Assessing glomerular filtration rate by estimation equations in kidney transplant recipients. Am J Transplant 2006; 6: 100.
29. National Kidney F. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1.
30. Levine GN, McCullough KP, Rodgers AM, et al. Analytical methods and database design: Implications for transplant researchers, 2005. Am J Transplant 2006; 6(5 Part 2): 1228.
31. Bureau of Labor Statistics. Consumer Price Index, US Average Medical Care. Available at: http://data.bls.gov/PDQ/servlet/SurveyOutput Servlet. Accessed August 7, 2009.
32. Wolfe RA, McCullough KP, Schaubel DE, et al. Calculating life years from transplant (LYFT): Methods for kidney and kidney-pancreas candidates. Am J Transplant 2008; 8(4 Part 2): 997.
33. Matas AJ, Schnitzler M. Payment for living donor (vendor) kidneys: A cost-effectiveness analysis. Am J Transplant 2004; 4: 216.